{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+Device+Arm&page=20", "query": { "intervention": "Study Device Arm", "page": 20 }, "page_size": 10 }, "pagination": { "page": 20, "page_size": 10, "total_count": 1735, "total_pages": 174, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+Device+Arm&page=21&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+Device+Arm&page=19&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T14:11:00.450Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06318338", "title": "Virtual Reality to Promote Relaxation Prior to Simulation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "Virtual Reality Program", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Abramson Cancer Center at Penn Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2024-04-08", "completion_date": "2025-02-12", "has_results": true, "last_update_posted_date": "2026-03-27", "last_synced_at": "2026-10-30T14:11:00.450Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06318338" }, { "nct_id": "NCT07630064", "title": "Flo Digital Contraceptive Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Contraception Use" ], "interventions": [ { "name": "Flo Digital Contraceptive", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Flo Health Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 3800, "start_date": "2026-04-22", "completion_date": "2028-01-10", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-10-30T14:11:00.450Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07630064" }, { "nct_id": "NCT04541563", "title": "Fisher Wallace Neurostimulation & Depression Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Fisher Wallace Cranial Electrotherapy Stimulator Device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "ProofPilot", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 175, "start_date": "2020-08-24", "completion_date": "2021-11-30", "has_results": false, "last_update_posted_date": "2021-02-11", "last_synced_at": "2026-10-30T14:11:00.450Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04541563" }, { "nct_id": "NCT03534219", "title": "Efficacy of the EarPopper Device in Children With Recurrent Otitis Media", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Recurrent Acute Otitis Media", "Acute Otitis Media" ], "interventions": [ { "name": "EarPopper", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 0, "start_date": "2018-07-24", "completion_date": "2021-01-01", "has_results": false, "last_update_posted_date": "2020-12-23", "last_synced_at": "2026-10-30T14:11:00.450Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03534219" }, { "nct_id": "NCT00858130", "title": "Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post Thrombotic Syndrome", "Deep Vein Thrombosis", "Venous Stasis Syndrome", "Venous Insufficiency", "Postphlebitic Syndrome" ], "interventions": [ { "name": "VeinOPlus", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2009-03", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2017-11-29", "last_synced_at": "2026-10-30T14:11:00.450Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00858130" }, { "nct_id": "NCT03783325", "title": "Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nevi and Melanomas" ], "interventions": [ { "name": "UV Counseling", "type": "BEHAVIORAL" }, { "name": "UV Photo", "type": "OTHER" }, { "name": "Biological Sample", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 71, "start_date": "2017-02-17", "completion_date": "2022-06-17", "has_results": false, "last_update_posted_date": "2023-10-23", "last_synced_at": "2026-10-30T14:11:00.450Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03783325" }, { "nct_id": "NCT04518410", "title": "ACTIV-2: A Study for Outpatients With COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Coronavirus", "Covid19" ], "interventions": [ { "name": "bamlanivimab 7000mg", "type": "BIOLOGICAL" }, { "name": "BRII-196+BRII-198", "type": "BIOLOGICAL" }, { "name": "AZD7442 (IV)", "type": "BIOLOGICAL" }, { "name": "AZD7442 (IM)", "type": "BIOLOGICAL" }, { "name": "SNG001", "type": "DRUG" }, { "name": "Camostat", "type": "DRUG" }, { "name": "BMS-986414 + BMS-986413", "type": "BIOLOGICAL" }, { "name": "SAB-185 (3,840 Units/kg)", "type": "BIOLOGICAL" }, { "name": "SAB-185 (10,240 Units/kg)", "type": "BIOLOGICAL" }, { "name": "CASIRIVIMAB + IMDEVIMAB", "type": "DRUG" }, { "name": "Placebo for Bamlanivimab 7000mg", "type": "DRUG" }, { "name": "Placebo for Bamlanivimab 700mg", "type": "DRUG" }, { "name": "Placebo for BRII-196+BRII-198", "type": "DRUG" }, { "name": "Placebo for SNG001", "type": "DRUG" }, { "name": "Placebo for Camostat", "type": "DRUG" }, { "name": "Placebo for SAB-185 (low dose)", "type": "DRUG" }, { "name": "Placebo for BMS-986414 + BMS-986413", "type": "DRUG" }, { "name": "Placebo for AZD7442 (IV)", "type": "DRUG" }, { "name": "Placebo for AZD7442 (IM)", "type": "DRUG" }, { "name": "Placebo for SAB-185 (high dose)", "type": "DRUG" }, { "name": "bamlanivimab 700mg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4044, "start_date": "2020-08-19", "completion_date": "2023-06-20", "has_results": true, "last_update_posted_date": "2024-08-02", "last_synced_at": "2026-10-30T14:11:00.450Z", "location_count": 207, "location_summary": "Anniston, Alabama • Athens, Alabama • Birmingham, Alabama + 143 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Cullman", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04518410" }, { "nct_id": "NCT06078735", "title": "Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atrial Fibrillation", "Hemostasis" ], "interventions": [ { "name": "Vascular closure with LockeT device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Kansas City Heart Rhythm Research Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2023-10-02", "completion_date": "2024-12", "has_results": false, "last_update_posted_date": "2024-10-29", "last_synced_at": "2026-10-30T14:11:00.450Z", "location_count": 6, "location_summary": "Overland Park, Kansas • Independence, Missouri • Kansas City, Missouri", "locations": [ { "city": "Overland Park", "state": "Kansas" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Independence", "state": "Missouri" }, { "city": "Independence", "state": "Missouri" }, { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06078735" }, { "nct_id": "NCT02779725", "title": "SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "SCC", "type": "BEHAVIORAL" }, { "name": "Nurse Practitioner", "type": "BEHAVIORAL" }, { "name": "DSS", "type": "BEHAVIORAL" }, { "name": "AT", "type": "BEHAVIORAL" }, { "name": "Symptom Severity", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 884, "start_date": "2017-08-07", "completion_date": "2022-09-30", "has_results": false, "last_update_posted_date": "2023-11-08", "last_synced_at": "2026-10-30T14:11:00.450Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02779725" }, { "nct_id": "NCT04002440", "title": "Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Efficacy", "Safety Issues" ], "interventions": [ { "name": "AMIA with SHARESOURCE Connectivity Platform", "type": "COMBINATION_PRODUCT" }, { "name": "HomeChoice PRO", "type": "DEVICE" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DEVICE" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 28, "start_date": "2018-11-08", "completion_date": "2022-04", "has_results": false, "last_update_posted_date": "2021-08-25", "last_synced_at": "2026-10-30T14:11:00.450Z", "location_count": 2, "location_summary": "Chula Vista, California • San Diego, California", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04002440" } ] }